These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Thermostability of poliovirus and measles vaccines. Melnick JL Dev Biol Stand; 1996; 87():155-60. PubMed ID: 8854012 [TBL] [Abstract][Full Text] [Related]
5. The replacement of water with deuterium oxide significantly improves the thermal stability of the oral poliovirus vaccine. Crainic R; Wu R; Otelea D; Georgescu MM; Delpeyroux F; Guillot S; Balanant J; Tardy-Panit M Dev Biol Stand; 1996; 87():161-6. PubMed ID: 8854013 [TBL] [Abstract][Full Text] [Related]
6. Elucidating mechanisms of thermostabilization of poliovirus by D2O and MgCl2. Chen CH; Wu R; Roth LG; Guillot S; Crainic R Arch Biochem Biophys; 1997 Jun; 342(1):108-16. PubMed ID: 9185619 [TBL] [Abstract][Full Text] [Related]
7. Studies on the attenuation phenotype of polio vaccines: poliovirus RNA polymerase derived from Sabin type 1 sequence is temperature sensitive in the uridylylation of VPg. Paul AV; Mugavero J; Yin J; Hobson S; Schultz S; van Boom JH; Wimmer E Virology; 2000 Jun; 272(1):72-84. PubMed ID: 10873750 [TBL] [Abstract][Full Text] [Related]
8. Studies on the loss of infectivity of live type 3 poliovaccine on storage. Pipkin PA; Minor PD Biologicals; 1998 Mar; 26(1):17-23. PubMed ID: 9637745 [TBL] [Abstract][Full Text] [Related]
9. Molecular studies of temperature-sensitive replication of the cold-adapted B/Ann Arbor/1/66, the master donor virus for live attenuated influenza FluMist vaccines. Chen Z; Aspelund A; Kemble G; Jin H Virology; 2008 Oct; 380(2):354-62. PubMed ID: 18804834 [TBL] [Abstract][Full Text] [Related]
10. Effects of adverse storage on live virus vaccines. Finter NB; Ferris R; Kelly A; Prydie J Dev Biol Stand; 1978; 41():271-6. PubMed ID: 753656 [TBL] [Abstract][Full Text] [Related]
11. Capsid and RNA stabilisation of the oral polio vaccine. Verheyden B; Andries K; Rombaut B Vaccine; 2001 Feb; 19(15-16):1899-905. PubMed ID: 11228359 [TBL] [Abstract][Full Text] [Related]
12. Heat stability of the lyophilized Sabin poliovaccine. Shiomi H; Urasawa T; Urasawa S Jpn J Infect Dis; 2003 Apr; 56(2):70-2. PubMed ID: 12824691 [TBL] [Abstract][Full Text] [Related]
13. Protein-primed RNA synthesis by purified poliovirus RNA polymerase. Paul AV; van Boom JH; Filippov D; Wimmer E Nature; 1998 May; 393(6682):280-4. PubMed ID: 9607767 [TBL] [Abstract][Full Text] [Related]
14. Regulatory considerations for new stabilised poliovaccines. Milstien JB; Lemon S Dev Biol Stand; 1996; 87():181-9. PubMed ID: 8854016 [TBL] [Abstract][Full Text] [Related]
15. The strategy of RNA viruses. Baltimore D Harvey Lect; 1974-1975; 70 Series():57-74. PubMed ID: 4377923 [No Abstract] [Full Text] [Related]
16. On stability of oral poliovirus vaccines. Mauler R; Gruschkau H Dev Biol Stand; 1978; 41():267-70. PubMed ID: 38157 [TBL] [Abstract][Full Text] [Related]
18. Visualization and functional analysis of RNA-dependent RNA polymerase lattices. Lyle JM; Bullitt E; Bienz K; Kirkegaard K Science; 2002 Jun; 296(5576):2218-22. PubMed ID: 12077417 [TBL] [Abstract][Full Text] [Related]
19. The thermostability of vaccines. Technologies for improving the thermostability of the oral poliovirus vaccine. Lemon SM; Milstien JB Int J Technol Assess Health Care; 1994; 10(1):177-84. PubMed ID: 8157450 [TBL] [Abstract][Full Text] [Related]
20. A deader vaccine? Minor P Nat Med; 2008 Feb; 14(2):120-1. PubMed ID: 18256612 [No Abstract] [Full Text] [Related] [Next] [New Search]